BIO logo

  • June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Company Presentations Wednesday

Wednesday, June 05, 2024
Company Presentation Theaters
Join us in the Company Presentation Theaters on the Exhibition Floor for Company Presentations. Click through to see all of the presentations and their details.
Loading
Search Filters
  • Date
  • Focus Area
  • Start time
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
Company Presentation Theater 1
    • Oncology
    TransCode Therapeutics
    Company Presentation Theater 1
    Zdravka Medarova
    Zdravka Medarova, Chief Scientific Officer - TransCode Therapeutics
    • Oncology
    Oxford Biotherapeutics
    Company Presentation Theater 1
    Mattthew Metzger
    Mattthew Metzger, Program, Alliance and Business Development Manager - Oxford Biotherapeutics
    • Oncology
    Cytimm Therapeutics
    Company Presentation Theater 1
    Haining Huang
    Haining Huang, President - Cytimm Therapeutics
    • Oncology
    Bexion Pharmaceuticals
    Company Presentation Theater 1
    Scott Shively
    Scott Shively, CEO - Bexion Pharmaceuticals
    • Oncology
    MAIA Biotechnology, Inc.
    Company Presentation Theater 1
    Vlad Vitoc
    Vlad Vitoc, Founder, Chairman and CEO - MAIA Biotechnology
    • Oncology
    Accuronix Therapeutics, Inc.
    Company Presentation Theater 1
    Bradley Keller
    Bradley Keller, President & CEO - Accuronix Therapeutic Inc.
    • Oncology
    Avelos Therapeutics
    Company Presentation Theater 1
    Young-Whan Park
    Young-Whan Park, CEO - Avelos Therapeutics
    • Oncology
    Rakuten Medical, Inc.
    Company Presentation Theater 1
    Abhijit Bhatia
    Abhijit Bhatia, Chief Operating Officer - Rakuten Medical, Inc.
    • Oncology
    Phrontline Biopharma
    Company Presentation Theater 1
    Tony (Zhaoyuan) Chen
    Tony (Zhaoyuan) Chen, CEO - Phrontline Biopharma
    • Oncology
    GenVivo, Inc.
    Company Presentation Theater 1
    Robert Johnson
    Robert Johnson, COO - GenVivo
    • Cell and Gene Therapy and Genome Editing
    Sernova Corp
    Company Presentation Theater 1
    Cynthia Pussinen
    Cynthia Pussinen, CEO - Sernova
    • Cell and Gene Therapy and Genome Editing
    Papillon Therapeutics, Inc.
    Company Presentation Theater 1
    Carter Cliff
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
    • Cell and Gene Therapy and Genome Editing
    Sarcomatrix Therapeutics Corp.
    Company Presentation Theater 1
    David Craig
    David Craig, President and CEO - Sarcomatrix Therapeutics Corp
    • Cell and Gene Therapy and Genome Editing
    Umoja Biopharma
    Company Presentation Theater 1
    David Fontana
    David Fontana, Chief Operating and Chief Business Officer - Umoja Biopharma
    • Cell and Gene Therapy and Genome Editing
    EG 427
    Company Presentation Theater 1
    Don Haut
    Don Haut, Chief Business Officer - EG 427
    • Cell and Gene Therapy and Genome Editing
    GeneVentiv Therapeutics, Inc.
    Company Presentation Theater 1
    Damon Race
    Damon Race, CEO - GeneVentiv Therapeutics, Inc.
    • Cell and Gene Therapy and Genome Editing
    SIRPant Immunotherapeutics Inc
    Company Presentation Theater 1
    Robert Towarnicki
    Robert Towarnicki, President & CEO - SIRPant Immunotherapeutics Inc.
    • Cell and Gene Therapy and Genome Editing
    Immunis, Inc.
    Company Presentation Theater 1
    Hans Keirstead
    Hans Keirstead, Chairman of the Board - Immunis, Inc.
    • Cell and Gene Therapy and Genome Editing
    Chimeric Therapeutics
    Company Presentation Theater 1
    Rebecca McQualter
    Rebecca McQualter, COO - Chimeric
    • Cell and Gene Therapy and Genome Editing
    Nanoscope Therapeutics
    Company Presentation Theater 1
    Sulagna Bhattacharya
    Sulagna Bhattacharya, CEO - Nanoscope Therapeutics
    • Inflammation
    Zymedi
    Company Presentation Theater 1
    Scott Kim
    Scott Kim, Chief Business Officer - Zymedi
Company Presentation Theater 2
    • Cell and Gene Therapy and Genome Editing
    Gritgen Therapeutics Co., Ltd.
    Company Presentation Theater 2
    Fenglan Wu
    Fenglan Wu, Co-founder and CEO - Gritgen Therapeutics
    • CNS/Neurological
    Sinopia Biosciences, Inc.
    Company Presentation Theater 2
    Iman Famili
    Iman Famili, President & CEO - Sinopia Biosciences, Inc.
    • CNS/Neurological
    Psilera
    Company Presentation Theater 2
    Chris Witowski
    Chris Witowski, Co-Founder and CEO - Psilera
    • CNS/Neurological
    Novoron Bioscience
    Company Presentation Theater 2
    Travis Stiles
    Travis Stiles, CEO & CSO - Novoron Bioscience, Inc.
    • CNS/Neurological
    Praetego Inc
    Company Presentation Theater 2
    Pepper Landson
    Pepper Landson, CEO - Praetego Inc
    • Dermatology
    Caliway Biopharmaceuticals Co.,Ltd.
    Company Presentation Theater 2
    April Yuan
    April Yuan, VP, Business Development & Public Affairs - Caliway
    • Multiple Therapeutics
    Nxera Pharma
    Company Presentation Theater 2
    Chris Cargill
    Chris Cargill, Chief Executive Officer - Nxera Pharma
    • Multiple Therapeutics
    Sanofi
    Company Presentation Theater 2
    Ulrich Wendt
    Ulrich Wendt, Global Head of Business Development, Immunology & Inflammation - Sanofi
    • Other
    Novartis Contract Manufacturing
    Company Presentation Theater 2
    Harald Oberegger
    Harald Oberegger
  10. Pfizer Inc.
    Company Presentation Theater 2
    • Oncology
    AUM Biosciences
    Company Presentation Theater 2
    Vishal Doshi
    Vishal Doshi, CEO - AUM Biosciences
    • Multiple Therapeutics
    Panolos Bioscience, Inc.
    Company Presentation Theater 2
    David Yang
    David Yang, Research Director - Panolos Bioscience, Inc.
    • Multiple Therapeutics
    Cytiva
    Company Presentation Theater 2
    Katrin Herrmann
    Katrin Herrmann, Senior Director, Global Strategic Accounts - Cytiva
    • Multiple Therapeutics
    Chugai Pharmaceutical Co., Ltd.
    Company Presentation Theater 2
    Yumiko Asano
    Yumiko Asano, Head of Chugai Partnering - Chugai Pharmaceutical Co., Ltd.
    • Multiple Therapeutics
    Hillhurst Bio
    Company Presentation Theater 2
    Andrew Gomperts
    Andrew Gomperts, President and CEO - Hillhurst Bio
    • Multiple Therapeutics
    Gan & Lee Pharmaceuticals
    Company Presentation Theater 2
    Spencer Carter
    Spencer Carter, Sr Director, US Business Development - Gan&Lee Pharmaceuticals
    • Multiple Therapeutics
    IRBM
    Company Presentation Theater 2
    Carlo Toniatti
    Carlo Toniatti, Chief Scientific Officer - IRBM
    • Multiple Therapeutics
    Yifan Pharmaceutical
    Company Presentation Theater 2
    Simon Li
    Simon Li, CEO/CMO of Evive Biotech and Vice President - Yifan Pharmaceutical
    • Multiple Therapeutics
    Brii Biosciences
    Company Presentation Theater 2
    Susannah Cantrell
    Susannah Cantrell, Chief Business Officer - Brii Biosciences
    • Multiple Therapeutics
    ProtaBody, Inc.
    Company Presentation Theater 2
    Justin Chartron
    Justin Chartron, CSO - ProtaBody, Inc.
Company Presentation Theater 3
    • Cell and Gene Therapy and Genome Editing
    T-knife Therapeutics
    Company Presentation Theater 3
    Elisa Kieback
    Elisa Kieback, Chief Technology Officer - T-knife Therapeutics
    • Cardiovascular
    ThromBio Holdings
    Company Presentation Theater 3
    Peter Bush
    Peter Bush, Chief Executive Officer - ThromBio
    • Tools/Drug Development Support Tech
    Ananda Devices
    Company Presentation Theater 3
    Margaret Magdesian
    Margaret Magdesian, CEO and Founder - Ananda Devices
    • Other
    ADP
    Company Presentation Theater 3
    Kevin Morrissey
    Kevin Morrissey, Sales Executive - ADP
    • Dermatology
    Alphyn Biologics, Inc.
    Company Presentation Theater 3
    Neal Koller
    Neal Koller, CEO - Alphyn Biologics
    • Dermatology
    Medicus Pharma LTD.
    Company Presentation Theater 3
    Erica Monaco
    Erica Monaco, Chief Operating Officer - Medicus Pharma
    • Dermatology
    Azitra Inc.
    Company Presentation Theater 3
    Travis Whitfill
    Travis Whitfill, Chief Operating Officer - Azitra Inc.
    • Dermatology
    DermaXon LLC
    Company Presentation Theater 3
    Philippe Diaz
    Philippe Diaz, CEO - Dermaxon Llc
    • Cardiovascular
    PlaqueTec
    Company Presentation Theater 3
    Simon Williams
    Simon Williams, General Manager - PlaqueTec
    • Cardiovascular
    Pelagos Pharmaceuticals, Inc.
    Company Presentation Theater 3
    Dan Watkins
    Dan Watkins, CEO - Pelagos Pharmaceuticals, Inc.
    • Cardiovascular
    InvivoSciences, Inc.
    Company Presentation Theater 3
    Ayla Annac
    Ayla Annac, CEO/Co-Founder - InvivoSciences, Inc.
    • Cardiovascular
    XyloCor Therapeutics
    Company Presentation Theater 3
    Albert Gianchetti
    Albert Gianchetti, Chief Executive Officer - XyloCor Therapeutics
    • Cardiovascular
    CeleCor Therapeutics
    Company Presentation Theater 3
    Robert Hillman
    Robert Hillman, CEO - CeleCor Therapeutics
    • Cardiovascular
    scPharmaceuticals
    Company Presentation Theater 3
    John Mohr
    John Mohr, SVP, Clinical Development and Medical Affairs - scPharmaceuticals
    • Tools/Drug Development Support Tech
    Lectenz Bio
    Company Presentation Theater 3
    Lori Yang
    Lori Yang, CEO and CSO - Lectenz Bio
    • Tools/Drug Development Support Tech
    Data4Cure, Inc.
    Company Presentation Theater 3
    Janusz Dutkowski
    Janusz Dutkowski, CEO and Co-founder - Data4Cure, Inc.
    • Tools/Drug Development Support Tech
    Pattern Computer
    Company Presentation Theater 3
    Mark Anderson
    Mark Anderson, Chair and CEO - Pattern Computer
    • Tools/Drug Development Support Tech
    Biopico Systems Inc
    Company Presentation Theater 3
    John Collins
    John Collins, CEO - Biopico Systems Inc
    • Tools/Drug Development Support Tech
    SPOC Proteomics
    Company Presentation Theater 3
    Bharath Takulapalli
    Bharath Takulapalli, Founder & CEO - SPOC Proteomics, Inc.
    • Tools/Drug Development Support Tech
    Cradle
    Company Presentation Theater 3
    Elise de Reus
    Elise de Reus, Co-Founder - Cradle
    • Cell and Gene Therapy and Genome Editing
    bBHC
    Company Presentation Theater 3
    Mindy Min -Sun oh
    Mindy Min -Sun oh, CEO - bBHC
Company Presentation Theater 4
    • Platform for Therapeutics
    BioMap
    Company Presentation Theater 4
    Per Greisen
    Per Greisen, President - BioMap
    • Platform for Therapeutics
    miRecule Inc.
    Company Presentation Theater 4
    Anthony Saleh
    Anthony Saleh, CEO/Founder - miRecule Inc.
    • Platform for Therapeutics
    Dyadic International Inc.
    Company Presentation Theater 4
    Mark Emalfarb
    Mark Emalfarb, Chief Executive Officer - Dyadic International, Inc.
    • Platform for Therapeutics
    PassPort Technologies, Inc.
    Company Presentation Theater 4
    Jeremiah Meloch
    Jeremiah Meloch, Business Development Representative - PassPort Technologies Inc.
    • Platform for Therapeutics
    Immuto Scientific
    Company Presentation Theater 4
    Faraz Choudhury
    Faraz Choudhury, CEO - Immuto Scientific
    • Platform for Therapeutics
    Kayothera
    Company Presentation Theater 4
    Mark Esposito
    Mark Esposito, Founder & VP - Kayothera Inc
    • Platform for Therapeutics
    Qprotyn Inc
    Company Presentation Theater 4
    Janak Vadgama
    Janak Vadgama, Head of BD and Customer Experience - Qprotyn Inc
    • Platform for Therapeutics
    Deep Genomics
    Company Presentation Theater 4
    Brendan Frey
    Brendan Frey, Founder, Chief Innovation Officer - Deep Genomics
    • Other
    Zymeworks
    Company Presentation Theater 4
    Emily Chen
    Emily Chen, Associate Director, Business Development - Zymeworks
    • Diagnostics and Personalized Medicine
    GenEndeavor LLC
    Company Presentation Theater 4
    Ricardo Mancebo
    Ricardo Mancebo, CEO - GenEndeavor LLC
    • Diagnostics and Personalized Medicine
    Inocras Inc.
    Company Presentation Theater 4
    Jehee Suh
    Jehee Suh, CEO - Inocras Inc.
    • Diagnostics and Personalized Medicine
    BERTIS
    Company Presentation Theater 4
    Donghan Lee
    Donghan Lee, Strategic planning team leader - BERTIS
    • CNS/Neurological
    Modality.AI, Inc.
    Company Presentation Theater 4
    David Suendermann-Oeft
    David Suendermann-Oeft, CEO - Modality.AI
    • CNS/Neurological
    InVivo Biosystems
    Company Presentation Theater 4
    Kat McCormick
    Kat McCormick, CEO - InVivo Biosystems
    • CNS/Neurological
    Aruna Bio
    Company Presentation Theater 4
    Stephen From
    Stephen From, CEO - Aruna Bio
    • CNS/Neurological
    Terran Biosciences
    Company Presentation Theater 4
    Sam Clark
    Sam Clark, Founder & CEO - Terran Biosciences
    • CNS/Neurological
    Guangzhou Magpie Pharmaceuticals Co., Ltd.
    Company Presentation Theater 4
    Yuqiang Wang
    Yuqiang Wang, Chief Executive Officer - Guangzhou Magpie Pharmaceuticals CO., LTD.
    • CNS/Neurological
    Kinoxis Therapeutics
    Company Presentation Theater 4
    Hugh Alsop
    Hugh Alsop, CEO - Kinoxis Therapeutics Pty Ltd
    • CNS/Neurological
    Freedom Biosciences
    Company Presentation Theater 4
    Dina Burkitbayeva
    Dina Burkitbayeva, CEO - Freedom Biosciences
    • CNS/Neurological
    Sobrera Pharma
    Company Presentation Theater 4
    Ann-Charlotte ROSENDAHL
    Ann-Charlotte ROSENDAHL, CEO - Sobrera Pharma
    • CNS/Neurological
    Manifold Bio
    Company Presentation Theater 4
    Gleb Kuznetsov
    Gleb Kuznetsov, Co-Founder & CEO - Manifold Bio

 
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS

Loading

Search